White Paper
Adding Real-World Evidence to a Totality of Evidence Approach for Evaluating Marketed Product Effectiveness
Nirosha Mahendraratnam, Kerra Mercon, Joy Eckert, Morgan Romine, Adam Kroetsch, Katherine Frank, Rachel Sherman Gregory Daniel, Mark McClellan
2019
Read MoreWhite Paper
Understanding the Need for Non-Interventional Studies Using Secondary Data to Generate Real-World Evidence for Regulatory Decision Making, and Demonstrating Their Credibility
Nirosha Mahendraratnam, Joy Eckert, Kerra Mercon, Katherine Frank, Morgan Romine, Adam Kroetsch, Rachel Sherman, Gregory Daniel, Mark McClellan
2019
Read MoreWhite Paper
Prescription Opioid Use and Medications to Treat Opioid Use Disorder in North Carolina Medicaid: 2013–2018
Aaron McKethan, PhD, Hilary Campbell, PharmD, JD, Chris Bush, MPH, Melissa A. Greiner, MS, Anna Hung, PharmD, PhD, MS, Andrew Olson, MPP, Jennifer Grant, MPH, Bradley Hammill, DrPH, Marisa Elena Domino, PhD, Jason Rotter, PhD, Alex Gertner, Maggie Holly
2019
Read MoreWhite Paper
Determining Real-World Data’s Fitness for Use and the Role of Reliability
Nirosha Mahendraratnam, Christina Silcox, Kerra Mercon, Adam Kroetsch, Morgan Romine, Nicholas R. Harrison, Adam Aten, Rachel Sherman, Gregory Daniel, Mark McClellan
2019
Read More